Eloxx Pharmaceuticals (ELOX) Environmental, Social & Governance (ESG) Data

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Environment Environmental Materials Natural Resources Nature Offset Package Packaging Pandemic Raw Materials Water Access African American Asian Benefits Black California Consumer Privacy Act Charitable Community Customer Cyber Cybersecurity Data Privacy Death Demographic Disability Diversity Drug Pricing Employee Employee Mobility Employee Retention Engagement Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Human Resources Incident Injuries Latinx LGBTQ Minority Perquisites Philanthropic Privacy Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Social Supplier Talent Training Union Workforce Workplace Safety Assessment Assurance Audit Bonus Bribe Bribery Chronic Classified Commitment Conflict of Interest Corporate Governance Corporate Purpose Department of Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Independence Independent Innovation Innovative Investigation Lawsuit Lead Independent Director Leadership Litigation Long-term Majority Materiality Mission Oversee Oversight Perquisite Purpose R&D Recoup Reputation Reputational Research and Development Responsibility Responsible Special Meeting Strategy Sustainable Targets Tax Transparency

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

(a) The annual meeting of stockholders of Eloxx Pharmaceuticals, Inc. (the “Company”) was held on May 19, 2021.

(b) Stockholders voted on the matters set forth below:

Proposal 1. Election of Directors:


Tomer Kariv	19,259,075	937,323	5,837,608
Sumit Aggarwal	20,095,235	101,163	5,837,608
Zafrira Avnur, Ph.D.	19,259,792	936,606	5,837,608
Ran Nussbaum	18,926,489	1,269,909	5,837,608
Rajesh Parekh, DPhil	20,136,166	60,232	5,837,608
Steven Rubin	17,365,649	2,830,749	5,837,608
Jasbir Seehra, Ph.D.	20,091,721	104,677	5,837,608
Gadi Veinrib	20,093,317	103,081	5,837,608
Alan Walts, Ph.D.	19,901,777	294,621	5,837,608

Proposal 2. Ratification of Appointment Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2021:

For			25,998,455
Against			9,022
Abstain			26,529
Broker Non-Votes			5,837,608

Proposal 3. Advisory Vote on Executive Compensation:

For			20,065,552
Against			98,341
Abstain			32,505
Broker Non-Votes			5,837,608